To match those profits under NovoCare, Hims would need 1-3.2x more customers, since branded Wegovy costs 1.5-3.6x more than compounded versions
Amit Kakar, PharmD #corporatewellness #glp1 #diabetesprevention #healthandwellness #pharmacistlife To view or add a comment, sign in 1 in 10 employers likely to drop GLP-1 coverage next year: report 1 in 10 U.S
The issue isn't necessarily where these products are made
The analysis of B12 in foods is a challenging task due to low concentrations of natural vitamers in non-supplemented foods, chemical instability of cobalamins, and potential presence of a wide range of structural analogs in the matrices [6, 7]
The authors extend their gratitude to Ms
The 2026 narrative review found vitamin D deficiency in 7.5% of patients at 6 months and 13.6% at 12 months